SPRINT研究全新分析:降压时有体位性低血压但无症状,不需要调整药物

2020-02-02 朱朱 中国循环杂志

高血压患者在治疗期间,会出现体位性低血压,即坐着时血压较高,而站立时血压降低。来自SPRINT研究的一项最新分析表明,高血压患者治疗期间如果出现无症状的体位性低血压,并不会增加心血管事件、晕厥、电解质异常、损伤性跌倒或急性肾衰竭等风险。研究者指出,有人认为,在老年高血压患者中,降压目标越严格,越可能导致体位性低血压和跌到。显然这项最新分析结果并不支持这一点。即便是在强化降压治疗(降压目标设定为收缩

高血压患者在治疗期间,会出现体位性低血压,即坐着时血压较高,而站立时血压降低。

来自SPRINT研究的一项最新分析表明,高血压患者治疗期间如果出现无症状的体位性低血压,并不会增加心血管事件、晕厥、电解质异常、损伤性跌倒或急性肾衰竭等风险。

研究者指出,有人认为,在老年高血压患者中,降压目标越严格,越可能导致体位性低血压和跌到。显然这项最新分析结果并不支持这一点。

即便是在强化降压治疗(降压目标设定为收缩压<120 mmHg)的情况下,高血压患者治疗期间出现的无症状性体位性低血压,都不应该成为下调降压药物的理由,即不应该调低降压药物用量或者减少降压药物种类。

但需要指出的是,该研究中体位性低血压是根据从坐位至站立后血压变化而定义的,且站立时收缩压<110 mmHg者被排除了。

在该研究中,中位随访3年期间,在以收缩压<120 mmHg或<140 mmHg为降压目标的患者中,分别有5.7%和5.0%出现体位性低血压。

研究者发现,无症状体位性低血压并未增加心血管事件、晕厥、电解质异常、损伤性跌倒、急性肾衰等的发生风险。

但是,体位性低血压会导致低血压相关住院或急诊就诊风险增加77%,心动过缓风险增加94%,这在两个降压目标不同的组中,情况相似。

该研究为一项前瞻性、随机对照、开放标签研究,纳入8156例年龄≥50岁的高血压患者,平均年龄68岁。患者坐着时收缩压为130~180 mmHg,但站立时收缩压≥110 mm Hg。

在该研究中,体位性低血压定义为:从坐着改站立1分钟后,收缩压下降≥20 mmHg或者舒张压下降≥10 mmHg。主要终点为心血管事件。

来源:Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events:Results From SPRINT. Hypertension, Originally published 27 Jan 2020

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2062423, encodeId=a35420624233e, content=<a href='/topic/show?id=9a6116651d1' target=_blank style='color:#2F92EE;'>#SPRINT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16651, encryptionId=9a6116651d1, topicName=SPRINT研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37d0457, createdName=yhj-time, createdTime=Fri Apr 24 02:50:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927541, encodeId=b484192e541bf, content=<a href='/topic/show?id=5194166480e' target=_blank style='color:#2F92EE;'>#SPRINT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16648, encryptionId=5194166480e, topicName=SPRINT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun May 10 20:50:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292059, encodeId=3bee12920596b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367399, encodeId=6649136e39905, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485058, encodeId=28df148505888, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2062423, encodeId=a35420624233e, content=<a href='/topic/show?id=9a6116651d1' target=_blank style='color:#2F92EE;'>#SPRINT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16651, encryptionId=9a6116651d1, topicName=SPRINT研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37d0457, createdName=yhj-time, createdTime=Fri Apr 24 02:50:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927541, encodeId=b484192e541bf, content=<a href='/topic/show?id=5194166480e' target=_blank style='color:#2F92EE;'>#SPRINT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16648, encryptionId=5194166480e, topicName=SPRINT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun May 10 20:50:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292059, encodeId=3bee12920596b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367399, encodeId=6649136e39905, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485058, encodeId=28df148505888, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
    2020-05-10 kalseyzl
  3. [GetPortalCommentsPageByObjectIdResponse(id=2062423, encodeId=a35420624233e, content=<a href='/topic/show?id=9a6116651d1' target=_blank style='color:#2F92EE;'>#SPRINT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16651, encryptionId=9a6116651d1, topicName=SPRINT研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37d0457, createdName=yhj-time, createdTime=Fri Apr 24 02:50:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927541, encodeId=b484192e541bf, content=<a href='/topic/show?id=5194166480e' target=_blank style='color:#2F92EE;'>#SPRINT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16648, encryptionId=5194166480e, topicName=SPRINT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun May 10 20:50:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292059, encodeId=3bee12920596b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367399, encodeId=6649136e39905, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485058, encodeId=28df148505888, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2062423, encodeId=a35420624233e, content=<a href='/topic/show?id=9a6116651d1' target=_blank style='color:#2F92EE;'>#SPRINT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16651, encryptionId=9a6116651d1, topicName=SPRINT研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37d0457, createdName=yhj-time, createdTime=Fri Apr 24 02:50:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927541, encodeId=b484192e541bf, content=<a href='/topic/show?id=5194166480e' target=_blank style='color:#2F92EE;'>#SPRINT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16648, encryptionId=5194166480e, topicName=SPRINT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun May 10 20:50:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292059, encodeId=3bee12920596b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367399, encodeId=6649136e39905, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485058, encodeId=28df148505888, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2062423, encodeId=a35420624233e, content=<a href='/topic/show?id=9a6116651d1' target=_blank style='color:#2F92EE;'>#SPRINT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16651, encryptionId=9a6116651d1, topicName=SPRINT研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37d0457, createdName=yhj-time, createdTime=Fri Apr 24 02:50:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927541, encodeId=b484192e541bf, content=<a href='/topic/show?id=5194166480e' target=_blank style='color:#2F92EE;'>#SPRINT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16648, encryptionId=5194166480e, topicName=SPRINT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun May 10 20:50:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292059, encodeId=3bee12920596b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367399, encodeId=6649136e39905, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485058, encodeId=28df148505888, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 03:50:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]

相关资讯

Stroke:高血压患者的颈动脉内膜中层厚度与首发卒中风险

由此可见,高血压患者基线cIMT与首发卒中风险之间存在显著的正相关。在那些具有较高平均动脉压或舒张压水平的患者中,这种关联甚至更强。

Hypertension:高血压孕妇血管生成标志物预后模型

由此可见,该研究的结果强调了血管生成生物标志物的附加值,以及将模型中sFlt-1/PlGF比率连续量化的优异性能。妊娠35周后,血管生成标记物的附加价值逐渐减弱。

J Diabetes: 高血压和糖尿病是“兄弟”!大庆研究称,糖耐量减低者,血压越高,糖尿病风险也越高

根据大庆研究的最新分析数据,对于糖耐量减低患者,高血压即促进糖耐量减低进展为糖尿病,而且也会增加该人群的长期心血管病风险。

PLos One:康复频率对类风湿性关节炎患者卒中风险的影响

由于全身炎症增强,类风湿性关节炎患者罹患卒中的风险较高。虽然定期训练已被证实可以减少人类受试者的炎症,但这项研究目的是确定康复频率增加是否可以预防卒中。   从2000年至2006年,在数据库中共确定了16,224例有灾难性疾病证明的类风湿性关节炎患者,其中663例在2013年底之前出现卒中。对年龄、性别以及类风湿性关节炎和卒中诊断时间的间隔进行统计学匹配之后,将642例无卒

山东枣庄40万高血压、糖尿病患者迎补贴新政 **补助300元

2019年12月31日,枣庄市政府新闻办举行新闻发布会,会上介绍了枣庄市关于完善城乡居民“两病”门诊用药保障机制有关情况。大众网·海报新闻记者从发布会上获悉,为进一步减轻城乡居民高血压、糖尿病患者门诊用药费用负担,按照山东省省医保局等四部门《关于完善城乡居民高血压糖尿病门诊用药保障机制的指导意见》,11月29日,枣庄市印发了《关于完善城乡居民高血压糖尿病门诊用药保障机制的通知》,部署完善城乡居民“

Hypertension:短期血压变异与高血压患者预后之间的相关性

由此可见,高血压患者短期血压变异性与总死亡率和心血管死亡率独立相关。